The contract fill / finish services market for biologics to grow at an annualized rate of ~10%, till 2030

January 7, 2021
Kevin123987

Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

 

To order this 480+ page report, which features 237 figures and 267 tables, please visit this link

 

Key Market Insights

  • Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products
  • The market landscape features a mix of both established players and new entrants; multiple biologics fill / finish service providers based in developed geographies have already adopted advanced fill / finish technologies
  • Vials represent the most prominent form of packaging used for biopharmaceutical interventions; with increasing demand for self-administration devices, syringes have also garnered significant attention
  • In fact, to acquire competencies across the value chain, stakeholders have actively invested in expanding their existing infrastructure and capabilities to cater to the evolving needs of both indigenous and international clients
  • Over the past six years, the fill / finish services domain has also witnessed significant partnership activity, with companies building strategic business relationships to consolidate their positions in the market
  • The outcome of consolidation is evident from our proprietary competitiveness analysis, based on several relevant parameters highlighting service and supplier strengths
  • Presently, the installed global contract fill / finish capacity, across various geographies, is estimated to be over 17 million units (in term of packaging containers)
  • The demand for contract fill / finish services for biologics is expected to increase in the coming years; it is likely that stakeholders will have to expand their respective capacities to ensure consistent supply
  • We expect biopharmaceutical developers to continue to outsource their fill / finish operations in the short to mid-term, resulting in an annualized growth rate of more than 10%
  • In the long-term, the projected opportunity is anticipated to be well distributed across various types of primary packaging, biological interventions and target disease indications

 

For more information, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill–finish-services-market-2019-2030/256.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Article Categories:
HEALTH

Leave a Comment